Unichem Laboratories block deals, bulk deals, insider trading and stake changes
NSE: UNICHEMLABBSE: 506690Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹487.75.
- Next results date: the board meets on 4 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹3,330 Cr1,036th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 Aug 2026
- 10.9
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹205 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 33.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 22 May 2026
- 1.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- 11.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹205 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 3.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 3.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 22 May 2026
- 0.17
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 40,08440.7% delivered
Unichem Laboratories insider trading
All 63 disclosures on record. The company's own latest disclosure on record is from Oct 2023.Insider trading, all companies
Sep 2023
- JATIN RAMANLAL MEHTA₹0.58 Cr13,200 sharesGave · Employees/Designated Employees · 21 Sep 2023 · disclosed 10 Oct · Others · held 13,200 before
- GERARD MAJELLA COLE₹0.20 Cr4,646 sharesGave · Other · 21 Sep 2023 · disclosed 9 Oct · Others · held 4,646 before
- RAJARAM PAI₹0.18 Cr4,000 sharesGave · Other · 21 Sep 2023 · disclosed 9 Oct · Others · held 4,000 before
- IPCA LABORATORIES LIMITED₹598 Cr1,35,79,571 sharesReceived · Promoters · 21 Sep 2023 · Others · stake 33.38% before, 52.67% after
- GERARD COLE₹0.19 Cr4,646 sharesSold or invoked · Designated Person · 20 Sep 2023 · disclosed 25 Sep
Aug 2023
- VANDANA PANDEY₹0.24 Cr6,000 sharesSold · Employees/Designated Employees · 22 Aug 2023 · disclosed 23 Aug · held 7,500 before, holds 1,500 after
- Dilip Janardan Kunkolienkar₹0.20 Cr5,000 sharesSold · Director · 21 Aug 2023 · disclosed 23 Aug · held 5,279 before, holds 279 after
- Dilip Janardan Kunkolienkar₹0.20 Cr5,000 sharesSold · Director · 17 Aug 2023 · disclosed 21 Aug · held 10,279 before, holds 5,279 after
- Dilip Janardan Kunkolienkar₹1.21 Cr30,000 sharesSold · Director · 14 Aug 2023 · disclosed 16 Aug · stake 0.06% before, 0.01% after
- JALESH BURYE₹0.13 Cr3,339 sharesSold · Employees/Designated Employees · 2 Aug 2023 · disclosed 16 Aug · held 3,339 before
- Dilip Janardan Kunkolienkar₹0.65 Cr16,259 sharesSold · Director · 2 Aug 2023 · disclosed 7 Aug · stake 0.08% before, 0.06% after
- Dr Prakash A. Mody₹945 Cr2,35,01,440 sharesGave · Promoters · 2 Aug 2023 · Others · stake 46.16% before, 12.78% after
Jul 2023
- Dilip Janardan Kunkolienkar₹0.75 Cr19,000 sharesSold · Director · 31 Jul 2023 · disclosed 2 Aug · stake 0.10% before, 0.08% after
- ANAND MAHAJAN₹0.11 Cr3,029 sharesSold · Director · 25 Jul 2023 · disclosed 27 Jul · held 3,029 before
- VERA MAHAJAN₹0.11 Cr2,836 sharesSold · Immediate relative · 25 Jul 2023 · disclosed 27 Jul · held 2,836 before
- ANAND Y MAHAJAN₹0.15 Cr4,029 sharesSold or invoked · Designated Person · 24 Jul 2023 · disclosed 29 Jul
- ANAND MAHAJAN₹0.04 Cr1,000 sharesSold · Director · 24 Jul 2023 · disclosed 25 Jul · held 4,029 before, holds 3,029 after
- VERA MAHAJAN₹0.08 Cr2,000 sharesSold · Directors Immediate Relative · 24 Jul 2023 · disclosed 25 Jul · held 4,836 before, holds 2,836 after
- Vera Anand Mahajan₹0.15 Cr4,000 sharesSold · Immediate relative · 21 Jul 2023 · disclosed 25 Jul · held 6,836 before, holds 2,836 after
- ANAND Y MAHAJAN₹0.08 Cr2,000 sharesSold · Director · 21 Jul 2023 · disclosed 25 Jul · held 5,029 before, holds 3,029 after
- ANAND MAHAJAN₹0.04 Cr1,000 sharesSold · Director · 21 Jul 2023 · disclosed 25 Jul · held 5,029 before, holds 4,029 after
- ANAND Y MAHAJAN₹0.11 Cr3,000 sharesSold or invoked · Designated Person · 20 Jul 2023 · disclosed 26 Jul
- VERA MAHAJAN₹0.08 Cr2,000 sharesSold · Directors Immediate Relative · 20 Jul 2023 · disclosed 21 Jul · held 8,836 before, holds 6,836 after
- ANAND Y MAHAJAN₹0.04 Cr1,000 sharesSold · Director · 20 Jul 2023 · disclosed 21 Jul · held 6,029 before, holds 5,029 after
- ANAND Y MAHAJAN₹0.11 Cr3,000 sharesSold or invoked · Designated Person · 19 Jul 2023 · disclosed 29 Jul
- ANAND Y MAHAJAN₹0.11 Cr3,000 sharesSold or invoked · Designated Person · 19 Jul 2023 · disclosed 26 Jul
- VERA MAHAJAN₹0.08 Cr2,000 sharesSold · Directors Immediate Relative · 19 Jul 2023 · disclosed 20 Jul · held 10,836 before, holds 8,836 after
- ANAND Y MAHAJAN₹0.04 Cr1,000 sharesSold · Director · 19 Jul 2023 · disclosed 20 Jul · held 7,029 before, holds 6,029 after
- Vera Anand Mahajan₹0.15 Cr4,000 sharesSold · Immediate relative · 19 Jul 2023 · disclosed 21 Jul · held 10,836 before, holds 6,836 after
Jun 2023
- ANAND Y MAHAJAN₹0.07 Cr1,750 sharesSold · Director · 5 Jun 2023 · disclosed 6 Jun · held 8,779 before, holds 7,029 after
- AAKIL A MAHAJAN₹0.23 Cr6,312 sharesSold · Immediate relative · 5 Jun 2023 · disclosed 6 Jun · held 6,312 before
- Vera Anand Mahajan₹0.10 Cr2,750 sharesSold · Immediate relative · 5 Jun 2023 · disclosed 6 Jun · stake 0.01% before, 0.01% after
- ANAND Y MAHAJAN₹0.13 Cr3,500 sharesSold or invoked · Designated Person · 2 Jun 2023 · disclosed 8 Jun
- ANAND Y MAHAJAN₹0.07 Cr1,750 sharesSold or invoked · Designated Person · 2 Jun 2023 · disclosed 7 Jun
- ANAND Y MAHAJAN₹0.07 Cr1,800 sharesSold · Director · 1 Jun 2023 · disclosed 5 Jun · held 10,579 before, holds 8,779 after
- Vera Anand Mahajan₹0.10 Cr2,800 sharesSold · Immediate relative · 1 Jun 2023 · disclosed 5 Jun · stake 0.02% before, 0.01% after
- ANAND Y MAHAJAN₹0.13 Cr3,600 sharesSold or invoked · Designated Person · 1 Jun 2023 · disclosed 5 Jun
May 2023
- Vera Anand Mahajan₹0.26 Cr6,950 sharesSold · Immediate relative · 31 May 2023 · disclosed 3 Jun · stake 0.03% before, 0.02% after
- ANAND Y MAHAJAN₹0.17 Cr4,450 sharesSold · Director · 31 May 2023 · disclosed 3 Jun · stake 0.02% before, 0.01% after
- ANAND Y MAHAJAN₹0.10 Cr2,700 sharesSold or invoked · Designated Person · 31 May 2023 · disclosed 2 Jun
- Mrs Vidhya Anantharaman₹0.28 Cr7,450 sharesSold · Immediate relative · 31 May 2023 · held 7,450 before
- Rupande Shah₹0.99 Cr26,496 sharesSold · Immediate relative · 29 May 2023 · disclosed 30 May · held 26,496 before
- PRAFUL ANUBHAI₹0.03 Cr682 sharesSold · Director · 29 May 2023 · disclosed 30 May · held 782 before, holds 100 after
Jan 2023
- ASHOK SHAH₹1.80 Cr49,908 sharesGave · 31 Jan 2023 · disclosed 1 Feb · Others · held 49,908 before
- ASHOK SHAH₹1.42 Cr49,908 sharesReceived · 20 Jan 2023 · disclosed 25 Jan · Others · holds 49,908 after, stake 0.07% after
Earlier, Jul 2015 to Mar 2021Hide earlier
Mar 2021
- Mrs Vidhya Anantharamam₹0.23 Cr7,450 sharesBought · Immediate relative · 31 Mar 2021 · disclosed 1 Apr · holds 7,450 after, stake 0.01% after
Mar 2020
- Suparna Mody Trust₹0.50 Cr34,516 sharesBought · Promoter Group · 30 Mar 2020 · disclosed 31 Mar · stake 0.02% before, 0.07% after
- Shwetambari Mody Trust₹0.37 Cr26,283 sharesBought · Promoter Group · 30 Mar 2020 · disclosed 31 Mar · stake 0.02% before, 0.06% after
- Supriya Mody Trust₹0.42 Cr29,951 sharesBought · Promoter Group · 30 Mar 2020 · disclosed 31 Mar · stake 0.02% before, 0.06% after
- Dr Prakash A. Mody₹0.64 Cr43,693 sharesBought · Promoters · 30 Mar 2020 · disclosed 31 Mar · stake 46.10% before, 46.16% after
- Dr Prakash A. Mody₹0.44 Cr36,307 sharesBought · Promoters · 26 Mar 2020 · disclosed 27 Mar · stake 46.06% before, 46.10% after
- Shwetambari Mody Trust₹0.18 Cr15,000 sharesBought · Promoter Group · 26 Mar 2020 · disclosed 27 Mar · holds 15,000 after, stake 0.02% after
- Suparna Mody Trust₹0.21 Cr17,500 sharesBought · Promoter Group · 26 Mar 2020 · disclosed 27 Mar · holds 17,500 after, stake 0.02% after
- Supriya Mody Trust₹0.18 Cr15,101 sharesBought · Promoter Group · 26 Mar 2020 · disclosed 27 Mar · holds 15,101 after, stake 0.02% after
Apr 2018
- Dilip Janardan Kunkolienkar₹0.44 Cr15,759 sharesGave · Director · 11 Apr 2018 · disclosed 12 Apr · ESOP · stake 0.07% before, 0.04% after
Oct 2017
- Vera Anand Mahajan9,583sharesReceived · Other · 11 Oct 2017 · disclosed 8 Nov · Others · holds 9,583 after
Sep 2017
- Rupande Shah24,000sharesReceived · Immediate relative · 4 Sep 2017 · disclosed 5 Sep · Gift · stake 0.01% before, 0.04% after
- Prafull Anubhai24,000sharesGave · Director · 4 Sep 2017 · disclosed 5 Sep · Gift · held 25,000 before, holds 1,000 after
Nov 2015
- Dr Prakash A. Mody₹27 Cr9,49,936 sharesReceived · Promoters · 30 Nov 2015 · Gift · held 4,13,37,342 before, holds 4,22,87,278 after
- Ms Shwetambari Mody₹27 Cr9,49,936 sharesGave · Promoters · 30 Nov 2015 · Inter-se-Transfer · held 9,49,936 before
- Shwetambari Mody9,49,936sharesGave · Promoter · 30 Nov 2015 · Gift · held 9,49,936 before
- Dr Prakash A Mody9,49,936sharesReceived · Promoter & Director · 30 Nov 2015 · Gift · held 4,13,37,342 before, holds 4,22,87,278 after
Jul 2015
- Suresh Kamath6,000sharesSold · Employee · 22 Jul 2015 · held 11,000 before
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Unichem Laboratories stake sales and purchases
All 12 disclosures on record.
Jun 2026
- SoldPortfolio Management Clients of Equity intelligence India Pvt Ltd and EQ India Fund0.43% of the company3,00,000 sharesholds 0.56% after11 Jun 2026 · filed under the 2% rule · Open Market
- SoldEquity Intelligence India Pvt Ltd0.43% of the company3,00,000 sharesholds 0.56% after11 Jun 2026 · filed under the 2% rule · Open Market
Sep 2023
- AcquiredIpca Laboratories Limited · promoter19.29% of the company1,35,79,571 sharesholds 52.67% after21 Sep 2023 · filed under the 2% rule
Aug 2023
- AcquiredHDFC Mutual Fund2.07% of the company14,55,954 sharesholds 7.41% after30 Aug 2023 · filed under the 2% rule · Open Market
- SoldDr. Prakash A Mody · promoter33.38% of the company2,35,01,440 sharesholds 12.78% after2 Aug 2023 · filed under the 2% rule
- AcquiredIpca Laboratories Limited33.38% of the company2,35,01,440 sharesholds 33.38% after2 Aug 2023 · filed under the 5% rule
Jun 2023
- SoldPortfolio Management Clients of Equity Intelligence India Pvt. Ltd. and EQ India Fund0.14% of the company1,02,300 sharesholds 2.92% after15 Jun 2023 · filed under the 2% rule · Open Market
Jan 2022
- AcquiredPortfolio Management Clients of Equity Intelligence India Pvt Ltd and EQ India Fund and PAC0.08% of the company54,850 sharesholds 5.10% after10 Jan 2022 · filed under the 5% rule · Open Market
Sep 2019
- AcquiredHDFC Mutual Fund: HDFC Trustee Company Ltd A/c -HDFC Small Cap Fund0.43% of the company3,00,000 sharesholds 5.34% after17 Sep 2019 · filed under the 5% rule · Open Market
Earlier, Sep 2016 to Dec 2017Hide earlier
Dec 2017
- SoldICICI Prudential Asset Management Company Limited1.01% of the company9,15,298 sharesholds 2.87% after28 Dec 2017 · filed under the 2% rule
Apr 2017
- SoldICICI Prudential Mutual Fund (the Fund) under its Various scheme0.06% of the company52,351 sharesholds 5.15% after13 Apr 2017 · filed under the 2% rule
Sep 2016
- SoldICICI Prudential Asset Management Company Ltd0.02% of the company20,514 sharesholds 7.20% after26 Sep 2016 · filed under the 2% rule · Open Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Unichem Laboratories block deals and bulk deals
Last 12 months, since 23 Oct 2025: 15 bulk deals, ₹298 Cr bought and ₹260 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Thursday 9 Jul 20261 firm · ₹39 Cr bought · ₹0 soldNet bought ₹39 Cr
- BoughtPOLUNIN EMERGING MARKETS SMALL CAP FUND LLCBought 6,00,901 at ₹646.440.85% of the company₹39 Cr
Thursday 11 Jun 20267 firms · ₹259 Cr bought · ₹260 Cr soldNet sold ₹1.49 Cr
- Both waysIRAGE BROKING SERVICES LLPBought 7,09,993 at ₹485.58Sold 7,58,636 at ₹487.661.08% of the companyNet −48,643 shares₹34 Cr bought
- Both waysQE SECURITIES LLPBought 6,14,846 at ₹490.39Sold 6,15,440 at ₹476.630.87% of the companyNet −594 shares₹30 Cr bought
- Both waysELIXIR WEALTH MANAGEMENT PRIVATE LIMITEDBought 6,15,503 at ₹488.36Sold 6,01,203 at ₹489.580.87% of the companyNet +14,300 shares₹30 Cr bought
- Both waysJUNOMONETA FINSOL PRIVATE LIMITEDBought 9,16,676 at ₹487.89Sold 9,23,655 at ₹488.311.31% of the companyNet −6,979 shares₹45 Cr bought
- Both waysNK SECURITIES RESEARCH PRIVATE LIMITEDBought 10,63,012 at ₹486.70Sold 10,63,012 at ₹486.941.51% of the companyNet nil₹52 Cr bought
- Both waysMICROCURVES TRADING PRIVATE LIMITEDBought 8,64,382 at ₹489.27Sold 8,64,382 at ₹489.481.23% of the companyNet nil₹42 Cr bought
- Both waysJUMP TRADING FINANCIAL INDIA PRIVATE LIMITEDBought 5,17,997 at ₹490.22Sold 5,17,997 at ₹490.110.74% of the companyNet nil₹25 Cr bought
Wednesday 2 Aug 20234 firms · ₹1,891 Cr bought · ₹1,891 Cr soldNet nil
- BoughtIPCA LABORATORIES LIMITEDBlock dealBought 2,35,01,440 at ₹402.2533.38% of the company₹945 Cr
- BoughtIPCA LABORATORIES LIMITEDBought 2,35,01,440 at ₹402.2533.38% of the company₹945 Cr
- SoldPRAKASH AMRUT MODYBlock dealSold 2,35,01,440 at ₹402.2533.38% of the company₹945 Cr
- SoldPRAKASH AMRUT MODYSold 2,35,01,440 at ₹402.2533.38% of the company₹945 Cr
Wednesday 14 Feb 20182 firms · ₹15 Cr bought · ₹40 Cr soldNet sold ₹25 Cr
- SoldNORDEA 1 SICAV INDIAN EQUITY FUND N2239LUASold 5,40,562 at ₹379.260.59% of the company₹21 Cr
- Both waysSMC GLOBAL SECURITIES LTD.Bought 3,95,005 at ₹379.52Sold 5,20,060 at ₹379.410.57% of the companyNet −1,25,055 shares₹15 Cr bought
Tuesday 18 Mar 20142 firms · ₹20 Cr bought · ₹20 Cr soldNet nil
- SoldANITA PRAKASH MODYSold 9,55,000 at ₹213.381.05% of the company₹20 Cr
- BoughtPRAKASH AMRUT MODYBought 9,55,000 at ₹213.381.05% of the company₹20 Cr
Wednesday 23 Dec 20091 firm · ₹6.12 Cr bought · ₹0 soldNet bought ₹6.12 Cr
- BoughtBAJAJ ALLIANZ LIFE INSURANCE CO. LTDBought 2,00,000 at ₹306.110.55% of the company₹6.12 Cr
Friday 20 Feb 20092 firms · ₹3.26 Cr bought · ₹3.26 Cr soldNet nil
- SoldMERRILL LYNCH CAPITAL MARKETS ESPANA S.A. SVBSold 2,28,276 at ₹143.000.63% of the company₹3.26 Cr
- BoughtPRIVATBANK IHAG ZURICH AGBought 2,28,276 at ₹143.000.63% of the company₹3.26 Cr
Thursday 15 May 20082 firms · ₹15 Cr bought · ₹15 Cr soldNet sold ₹0.40 Cr
- SoldFRANKLIN TEMPLETON MUTUAL FUNDSold 10,57,230 at ₹145.052.93% of the company₹15 Cr
- BoughtRELIANCE CAPITAL TRUSTEE CO.LTD.Bought 10,30,000 at ₹145.002.86% of the company₹15 Cr
Monday 17 Dec 20072 firms · ₹11 Cr bought · ₹10 Cr soldNet bought ₹0.14 Cr
- BoughtRELIANCE CAP.TRUSTEE CO.TLD.A/C LONG TERM EQUITY FUNDBought 5,50,000 at ₹192.991.53% of the company₹11 Cr
- SoldNEW VERNON PRIVATE EQUITY LIMITEDSold 5,42,523 at ₹193.001.51% of the company₹10 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 27 deals on record from 4 Jan 2004.